Amneal Pharmaceuticals (Germany) Today
| 2DT Stock | EUR 8.25 0.50 6.45% |
Performance6 of 100
| Odds Of DistressOver 60
|
Amneal Pharmaceuticals is trading at 8.25 as of the 4th of February 2025. This is a 6.45 percent increase since the beginning of the trading day. The stock's lowest day price was 8.25. Amneal Pharmaceuticals has more than 60 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 5th of January 2025 and ending today, the 4th of February 2025. Click here to learn more.
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. Amneal Pharmaceuticals, Inc. was founded in 2002 and is based in Bridgewater, New Jersey. The company has 151.48 M outstanding shares. More on Amneal Pharmaceuticals
Moving against Amneal Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Amneal Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Amneal Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Amneal Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Chintu Patel |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Amneal Pharmaceuticals (2DT) is traded on Frankfurt Exchange in Germany and employs 7,000 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 712.21 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amneal Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Amneal Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Amneal Pharmaceuticals classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 151.48 M outstanding shares.
Amneal Pharmaceuticals has accumulated about 452.1 M in cash with 241.82 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.04.
Check Amneal Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationAmneal Pharmaceuticals holds a total of 151.48 Million outstanding shares. Over half of Amneal Pharmaceuticals' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Amneal Pharmaceuticals. Please watch out for any change in the institutional holdings of Amneal Pharmaceuticals as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Amneal Ownership Details
Amneal Pharmaceuticals Risk Profiles
Although Amneal Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Amneal Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.76 | |||
| Semi Deviation | 1.9 | |||
| Standard Deviation | 2.28 | |||
| Variance | 5.2 |
Amneal Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Amneal Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Amneal Pharmaceuticals Corporate Management
Elected by the shareholders, the Amneal Pharmaceuticals' board of directors comprises two types of representatives: Amneal Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amneal. The board's role is to monitor Amneal Pharmaceuticals' management team and ensure that shareholders' interests are well served. Amneal Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amneal Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sanjay Jain | President - India | Profile | |
| Shlomo Yanai | Independent Director | Profile | |
| John Kiely | Independent Director | Profile | |
| Gautam Patel | Director | Profile | |
| Nikunj Patel | Head Ltd | Profile |
Other Information on Investing in Amneal Stock
Amneal Pharmaceuticals financial ratios help investors to determine whether Amneal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amneal with respect to the benefits of owning Amneal Pharmaceuticals security.